European Drug Usage Survey for Amyvid (I6E-MC-AVBF)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/24810
• EU PAS number:
  EUPAS6736
• Study ID:
  24810
• Official title and acronym:
  European Drug Usage Survey for Amyvid (I6E-MC-AVBF)
• DARWIN EU® study:
  No
• Study countries:
  Italy

  Spain

  United Kingdom
• Study description:
  This is a survey of physicians who refer patients for Amyvid PET scans. This study seeks to establish the usage patterns of Amyvid in European clinical practice.
• Study status:
  Finalised

Research institution and networks

Institutions

Real World Evidence Solutions, IMS Health

France

Study timelines

Date when funding contract was signed

Planned: 15/12/2014

Actual: 15/12/2014

Study start date

Planned: 15/12/2014

Actual: 17/12/2014

Date of final study report

Planned: 01/06/2017

Actual: 28/10/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company

Study protocol

Initial protocol

European drug usage survey for Amyvid I6E-MC-AVBF - redacted approved protocol

Updated protocol

AVBF PASS Protocol_Redacted

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)